China News Agency, Taipei, July 28. Taiwan reopened the registration of new crown pneumonia vaccine intentions on the 27th, and added Taiwan's local vaccine "high-end" new crown pneumonia vaccine options.

However, the vaccine passed the "Emergency Use Authorization" (EUA) before the third phase of clinical trials was completed. People on the island were more suspicious, and the appointment was cold.

  According to reports from the Central News Agency, United News Network and other media, Taiwan reopened the "COVID-19 Vaccine Intention Registration and Appointment System" on the afternoon of the 27th. The public can choose between AZ vaccine, Modena vaccine and high-end vaccine. You can also change the previous selection.

  According to statistics from Taiwan’s “Pandemic Epidemic Command Center”, as of 1 pm on the 28th, about 8.279 million people in Taiwan have completed their wish registration, of which 50.02% are willing to administer Modena vaccine or AZ vaccine, and only wish to administer it. Dana vaccine and those who only want to administer AZ vaccine accounted for 39% and 4.98%, respectively.

The number of people receiving high-end vaccines is less than 500,000, which is relatively low.

  Previously, the AZ vaccine caused a high rate of serious adverse events, and people on the island had high doubts about it.

However, the newly added high-end vaccines have not gained more favor.

According to reports, the high-end vaccine is a recombinant protein vaccine, and the third phase clinical trial has not yet been conducted.

Taiwan’s “Food and Drug Administration” adopted an immune bridging method for assessment. The neutralizing antibody data of high-end vaccines was not inferior to the results of neutralizing antibodies of AZ vaccines vaccinated by people on the island. It passed the EUA review of high-end vaccines on the 19th of this month.

Due to the closed-door approach of the expert review meeting and the unannounced discussion process, Taiwan scholars and opposition parties questioned it as a "black box operation."

  According to the "United Daily News" report, Taiwanese medical expert Chen Peizhe has publicly stated that the above-mentioned research data of neutralizing antibodies does not equal the protective power of the actual treatment and has no reference value.

The Taiwan authorities once claimed that if the local vaccine wants to obtain EUA, it must be based on international standards, but in the end they "created a Taiwan-specific censorship system", basically saying one thing and doing one thing.

  China Times News reported on the 28th that netizens lacked confidence in local vaccines due to the lack of confidence in local vaccines. They were also worried that they would not be able to enter other countries smoothly after being vaccinated with high-end vaccines that have not been internationally certified.

In addition, many of the Internet opinion leaders in the DPP who supported local vaccines were found to have actually been vaccinated with imported vaccines, which also made the public unconvinced.

  On the same day, Taiwanese leader Tsai Ing-wen announced on his personal Facebook page that he had registered for high-end vaccines and called on the public to register as soon as possible. He also said that "safe, effective, legal, and scientifically-compliant vaccines will be provided for everyone to vaccinate."

Zhongshi News.com stated that this move is an attempt to restore the local vaccine's sluggish willingness to administer vaccines, "but judging from the reason why the people least want to fight, everyone hopes to give an explanation on the issue of opaque review standards."

  On the same day, Taiwan added 18 newly confirmed cases of new coronary pneumonia and 2 imported cases from abroad.

So far, a total of 15,619 cases have been confirmed in Taiwan, including 14,306 local cases, 1,260 imported cases, and 787 deaths.

(Finish)